I have come to the conclusion BG is only good for a swing/trade as earnings never consistently higher. From mid 60s to 80s...as it will find it challenging to go over 90 and stay over 100 where it belongs if not for the many missteps, reorganizations, etc.
Maybe time for new management or some other company make an offer to take them out.
If the dividend gets reduced or eliminated, heads will roll.
BG stock deserves better.
At one time BG was to buy Corn Products (named changed to INGR). Look at INGR now compared to BG, from 30s to over 90 going over 100 next year.
A bull with VRX to what target price you have in mind?
Yes, be strong if you bought VRX at 250 and have faith it will not go to zero.
Ackman bought more shares on the down, and VRX price continue to head down.
Up 7.xx today but short-covering just about over.
No rules broken, deal goes through.
Tax experts reviewed Treasury new guidelines and saw nothing standing in its way to prevent merger.
What can he say...it is un American and must be disallowed?
Clinton to ask Congress pass new rules and make it retroactive?
PFE won't repeat ABBV's cancel merger of Shire purchase because of Treasury and Obama's scolding.
That makes AGN worth $380, however, you won't see AGN rise that high.
More likely only up $30 with some complaining AGN worth north of $400.
Many wondering how much cash will be thrown into the pot - $10 to $40 per share for just 10%.
This is just the beginning of Saunder's legacy.
Once the merger finally consumed in 2016, more deals as Saunders takes over.
This is his vision...big get bigger.
PFE can now celebrate - great company but stock price has been so-so appreciation over the years.
Friendly deal compared to how VRX ways of doing things.
Looking back if Actavis wasn't the white knight for the Botox maker Allergan, this merger would never have happened.
All eyes are focused on PFE stock price come Monday's opening.
If it goes south under 30, the deal worth less.
If PFE trades over 35, the deal has Wall St. blessings (unlikely).
so many negative news on CMG and stock price hasn't tanked ---yet.
Just a 12% decline today, no 20% to 50% nose dive.
Give credit to the market maker stepping in.
Read won't be in that position for very long; my guess no longer than a year before sailing into the sunset and enjoying his 2nd career in retirement.
Then Saunders takes over...PFE/AGN will be in good hands if his past history is any guide to success.
Saunders has more visions as the big will get bigger. All his deals are on friendly and not hostile.
His purchase of Forest Labs was the clincher and old AGN deal away from VRX.
eps report did not move stock price higher but lower.
Wall St. waiting for GILD next purchase and whether a good fit (how much longer the wait?)
only then will GILD move higher over 120.
Therefore, will the purchased company be a name brand like BMY or AMGN or some unknown value-discovery drug waiting for approval like the one they bought previously.
Otherwise GILD dividend supporting stock to stay above 100 (yawn)
XPO share price movement will tell if BJ's plan/goal is working.
XPO needs to stay over 30 and trade 35-40 before 12/31/15.
Looking to see if XPO can make it back to 45-50 in 2016 and head over 50.
No more acquisitions and waiting for better eps in 4th quarter instead of negative eps.
Today markets have big gains, but VRX not following.
Good indication this is a one-day spike for short-covering.
Next week resume going south, but on a steady 2-3 bucks per day.
Then the December 2 Congressional hearings.
Bought on the dips and waited for the bounce, sold at a profit.
Head still on shoulders (lol).
SSO no double dip return to 53 this year...maybe in 2016.
Did you cover your short position yet?
Seeking Alpha has an article out on AGN PFE merger...google that one.
There is a breakup fee of $4.5B if merger doesn't go through.
Looks like a done deal regardless of Treasury threat.
Don't believe another big pharma company will step in and make waves to the deal. Won't be VRX.
What is the target price you're looking to sell at - 350?
Will be of great interest what kind of guidelines Lew coming out with to make the merger go away.
That's what the fear is currently and why AGN trades lower.
Tuna can go to VRX board and make waves on the long side (lol)
Treasury sticking their nose in this merger trying to change the rules so inversion does not take place;
Probably not up 60 tomorrow, just 30-50.
IMO PFE already anticipated treasury new rules and will counter with CPA tax experts.
Once this merger is done and Saunders takes over for Read, he has bigger plans in store per recent interviews. He didn't say, but hinted it is probably just in the 3rd inning of the ballgame.
In other words, look for more mega deals...like AMGN.
Congress/Obama/Clinton will take a stab to prevent via inversion rules, but won't win.
AGN ~ 350 to 400 target
time-value of money as it takes months before transaction goes through.
In other words ARG will approach 143 near completion of deal, if no hitches.
ARG if no other bids, won't go over 143
ceo stays on to get paid.
resign he doesn't get paid.
maybe waiting to get fired and sweetheart package compensation.
First VRX must go below 70...how long will it take - give it 2 or 3 more days.
One day VRX will spike up $5 to $10 to scare many to short cover.
Yeah, with no new news coming out VRX still goes lower.